Le Lézard
Classified in: Health, Science and technology
Subject: ANNUAL MEETINGS

Zenith Announces Annual and Special Meeting of Shareholders


CALGARY, Alberta, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith") announced today that its Annual and Special Meeting of Shareholders (the "Meeting") is to be held Thursday, October 31, 2019 at Mount Royal University, Roderick Mah Centre for Continuous Learning ? Ross Glen Hall (Room EC1040), 4825 Mount Royal Gate SW, Calgary, Alberta.

A Notice of Meeting and Management Information Circular, containing further details including matters to be considered at the Meeting and the start time, will be delivered to shareholders and filed on SEDAR at www.sedar.com on or about Monday, September 30, 2019.

Following the formal business of the Meeting, Donald McCaffrey, President and Chief Executive Officer, will provide a corporate update presentation.

About Zenith

Zenith Capital Corp. is a biotechnology investment company originally spun out of Resverlogix Corp. (TSX: RVX) in 2013. Zenith Epigenetics Ltd., a wholly-owned subsidiary of Zenith Capital Corp., is a clinical stage biotechnology company focused on the discovery and development of novel therapeutics for the treatment of cancer and other disorders with significant unmet medical need. Zenith Epigenetics is developing various novel combinations of BET inhibitors with other targeted agents. The lead compound, ZEN-3694, is in clinical development for metastatic Castration Resistant Prostate Cancer ("mCRPC") and Triple Negative Breast Cancer.

For further information, please contact:

Investor Relations & Communications
Phone : 587-390-7865
Email : info@zenithepigenetics.com
Website : www.zenithepigenetics.com
           

                                                           
                                                                       



These press releases may also interest you

at 05:32
As of July 8th 2020, the Chancellor, Rishi Sunak, announced a higher threshold for stamp tax in the UK until March 31st 2021. There are several positive outcomes from this new announcement. Primarily this will affect those interested in purchasing...

at 05:08
RaySearch Laboratories AB (publ) has entered into a licensing and distribution agreement with TAE Life Sciences, manufacturer of the Alphabeamtm System for boron neutron capture therapy (BNCT). BNCT is a biologically targeted radiation therapy that...

at 05:00
Today, Texas Commissioner of Agriculture, Sid Miller, who heads the Texas State Office of Rural Health, thanked Yaniv Sarig of Mohawk Group for their generous contribution of needed Personal Protective Equipment (PPE) for Texas's 163 rural and...

at 04:50
The global follicle stimulating hormone market size is expected to enlarge by the forecast period, according to Radiant Insights. Follicle stimulating hormone (FSH) and luteinizing hormone (LH) is responsible for production of healthy eggs in men and...

at 04:05
Croma is always committed to deepening its product portfolio to support customers in their daily work. With pure HA, Croma has developed a highly concentrated liquid skin mask in a minimalistic formula containing 1.8% of hyaluronic acid to smooth,...

at 03:11
SuperCom , a global provider of secure solutions for the e-Government, Public Safety, HealthCare, and Finance sectors, announces the closing of the private placement financing previously announced on July 8, 2020 raising gross proceeds of $3.2...



News published on 22 august 2019 at 17:25 and distributed by: